Den femte undersøgelse viste, at de patienter, som fik RoActemra alene, havde større sandsynlighed for at respondere end de patienter, som fik methotrexat alene.
The fifth study showed that patients receiving RoActemra on its own were more likely to respond than those taking methotrexate on its own.